| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1404456-53-6 | GSK 2830371;5-(((5-Chloro-2-methyl-3-pyridinyl)amino)methyl)-N-((1S)-1-(cyclopentylmethyl)-2-(cyclopropylamino)-2-oxoethyl)-2-thiophenecarboxamide | C23H29ClN4O2S |
| 1404463-12-2 | N-(1-(5-O-(Bis(4-methoxyphenyl)phenylmethyl)-3-O-((bis(1-methylethyl)amino)(2-cyanoethoxy)phosphino)-2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-1,2-dihydro-2-oxo-4-pyrimidinyl)benzamide | C46H51FN5O8P |
| 1404463-20-2 | N-(9-(5-O-(Bis(4-methoxyphenyl)phenylmethyl)-3-O-((bis(1-methylethyl)amino)(2-cyanoethoxy)phosphino)-2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-6,9-dihydro-6-oxo-1H-purin-2-yl)-2-methylpropanamide | C44H53FN7O8P |
| 1404477-10-6 | Dapagliflozin Bromo Keto Impurity;(5-bromo-2-chlorophenyl)-(2-ethoxyphenyl)methanone | C15H12BrClO2 |
| 1404480-51-8 | 6-Bromoimidazo(1,2-a)pyrazine-3-carboxylic acid | C7H4BrN3O2 |
| 1405128-33-7 | tert-butyl N-((3S,5R)-5-methyl-1-(3-nitro-4-pyridyl)-3-piperidyl)carbamate | C16H24N4O4 |
| 1407183-70-3 | 3-(4-(9H-Carbazol-9-yl)phenyl)-9-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)-9H-carbazole | C51H33N5 |
| 1407229-73-5 | Imatinib impurity M;1,4-Bis(4-carboxybenzyl)-1-methylpiperazin-1-ium | C21H25N2O4+ |
| 1407966-77-1 | (R)-3-[1-(1-Acryloylpiperidin-3-yl)-4-amino-1H-pyrazolo[3,4-d]pyrimidin-3-yl]-N-(4-isopropyl-5-methylphenyl)benzamide | C30H33N7O2 |
| 1407991-24-5 | (2R)-2-(Aminomethyl)-4,4-difluoro-1-pyrrolidinecarboxylic acid 1,1-dimethylethyl ester | C10H18F2N2O2 |
| 1407991-26-7 | N-(((2R)-4,4-Difluoro-2-pyrrolidinyl)methyl)carbamic acid 1,1-dimethylethyl ester | C10H18F2N2O2 |
| 1407997-80-1 | (R)-1-Boc-pyrrolidine-3-carboxylic acid hydrazide;tert-butyl (3R)-3-(hydrazinecarbonyl)pyrrolidine-1-carboxylate | C10H19N3O3 |
| 1408058-12-7 | 4-Methoxy-2-(trifluoromethyl)benzenecarboximidamide hydrochloride (1:1) | C9H9F3N2O.HCl |
| 1408058-14-9 | 5-(Chlorosulfonyl)pentanoic acid methyl ester | C6H11ClO4S |
| 1408064-71-0 | 3-((4-(Dimethylamino)-1-oxo-2-buten-1-yl)amino)-N-(4-((4-(3-pyridinyl)-2-pyrimidinyl)amino)phenyl)benzamide;JNK-IN-7 | C28H27N7O2 |
| 1408074-42-9 | 5-((tert-Butoxycarbonyl)amino)tetrahydro-2H-pyran-2-carboxylic Acid | C11H19NO5 |
| 1408074-48-5 | 8-Oxa-2-azaspiro(4.5)decane hydrochloride (1:1) | C8H15NO.HCl |
| 1408074-83-8 | Tert-butyl 4-amino-3,3-difluoropyrrolidine-1-carboxylate | C9H16F2N2O2 |
| 1408075-19-3 | 7-Amino-2-azaspiro(3.5)nonane-2-carboxylic acid 1,1-dimethylethyl ester | C13H24N2O2 |
| 1408075-88-6 | 1-Methyl-3-oxocyclobutanecarboxylic acid methyl ester;Methyl 1-methyl-3-oxocyclobutanecarboxylate | C7H10O3 |
| 1408075-90-0 | 7-Oxo-5-oxa-2-azaspiro(3.4)octane-2-carboxylic acid 1,1-dimethylethyl ester | C11H17NO4 |
| 1408075-99-9 | trans-3-Fluorocyclobutanamine hydrochloride (1:1) | C4H8FN.HCl |
| 1408076-03-8 | 3,3-Difluoro-1-methylcyclobutanamine | C5H9F2N |
| 1408076-07-2 | 2,5-Diazaspiro(3.5)nonane-5-carboxylic acid 1,1-dimethylethyl ester ethanedioate (1:1) | C12H22N2O2.C2H2O4 |
| 1408077-50-8 | Dapagliflozin Impurity 61;4-Chloro-3-(4-ethoxybenzyl)phenol | C15H15ClO2 |
| 1408238-36-7 | Ethyl 2-(((4-((((hexyloxy)carbonyl)amino)iminomethyl)phenyl)amino)methyl)-1-methyl-1H-benzimidazole-5-carboxylate | C26H33N5O4 |
| 1408238-41-4 | 2-(((4-(Aminoiminomethyl)phenyl)amino)methyl)-1-methyl-1H-benzimidazole-5-carboxylic acid ethyl ester | C19H21N5O2 |
| 1408282-25-6 | 3-(2-(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)ethyl)-6-fluoro-1H-indole-4-carboxylic acid methyl ester | C20H15FN2O4 |
| 1408282-26-7 | 8-Fluoro-1,3,4,5-tetrahydro-6H-pyrrolo(4,3,2-ef)(2)benzazepin-6-one | C11H9FN2O |
| 1410783-24-2 | 5-(tert-Butyl)-(1,1'-biphenyl)-2-amine;4-tert-butyl-2-phenylaniline | C16H19N |
| 1410880-22-6 | 3-((4-(Dimethylamino)-1-oxo-2-buten-1-yl)amino)-N-(3-methyl-4-((4-(3-pyridinyl)-2-pyrimidinyl)amino)phenyl)benzamide;JNK Inhibitor XVI | C29H29N7O2 |
| 1412427-05-4 | 2-Amino-2'-C-methyladenosine 2',3',5'-tribenzoate | C32H28N6O7 |
| 1412439-84-9 | (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis(4-nitrophenyl)-diindeno(7,1-de:1',7'-fg)(1,3,2)dioxaphosphocin-5-oxide | C29H21N2O8P |
| 1412898-66-8 | Docetaxel Impurity 19;2-Debenzoyl-2-pentenoyl Docetaxel | C41H55NO14 |
| 1413367-76-6 | (3R,5S)-rel-3-Amino-5-methyl-1-piperidinecarboxylic acid 1,1-dimethylethyl ester | C11H22N2O2 |
| 1413732-47-4 | Copper(1+) trifluoromethanethiolate - 2,2'-bipyridine (1:1:1) | C11H8CuF3N2S |
| 1414378-14-5 | 3-(5-(3,5-Dichloro-4-fluorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl)-5,6-dihydro-4H-cyclopenta(c)thiophene-1-carboxylic acid methyl ester | C19H13Cl2F4NO3S |
| 1414469-59-2 | 2,2',2'-(1,3,5-Triazine-2,4,6-triyltris(oxy-4,1-phenylenecarbonyloxy))tris(N,N,N-trimethylethanaminium) iodide (1:3) | C39H51N6O9.I3 |
| 1414642-43-5 | 2-Amino-N-(2,2-difluoroethyl)acetamide hydrochloride (1:1) | C4H8F2N2O.HCl |
| 1414933-80-4 | Ritonavir EP Impurity R;Thiazol-5-ylmethyl (2S,3S,5R)-3-hydroxy-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido(-3-methylbutanamido)-1,6-diphenylhexan-2-ylcarbamate | C37H48N6O5S2 |
| 1414956-67-4 | 7-Bromo-4(1H)-cinnolinone | C8H5BrN2O |
| 1414960-66-9 | (2S)-3-Butyn-2-amine hydrochloride | C4H7N.HCl |
| 1414973-10-6 | B-[2-(Hydroxymethyl)-4-pyridinyl]-boronic Acid | C6H8BNO3 |
| 1415089-89-2 | Methyl 5-cyano-2-(trifluoromethyl)benzoate | C10H6F3NO2 |
| 1415238-25-3 | 1,3,6,8-Tetrakis(4-formylphenyl)pyrene | C44H26O4 |
| 1415238-77-5 | 1H-Imidazol-1-yl(2-methyl-3-furanyl)methanone | C9H8N2O2 |
| 1415334-59-6 | (10-(1,1':3',1''-Terphenyl)-5'-yl-9-anthracenyl)boronic acid | C32H23BO2 |
| 1415477-23-4 | 4-Bromo-7-chloro-6-((4-cyclopropylphenyl)methyl)-2,3-dihydrobenzofuran | C18H16BrClO |
| 1415559-43-1 | N-(5-((6-(3-(1,3-Dioxoisoindol-2-yl)phenyl)pyrimidin-4-yl)amino)-2-methylphenyl)methanesulfonamide;CDK9 inhibitor | C26H21N5O4S |
| 1415560-64-3 | GSK256066 trifluoroacetate;6-((3-((Dimethylamino)carbonyl)phenyl)sulfonyl)-4-((3-methoxyphenyl)amino)-8-methyl-3-quinolinecarboxamide 2,2,2-trifluoroacetate (1:1) | C27H26N4O5S.C2HF3O2 |